Home exercise program for FSHD fatigue and pain
Part of Pain clinical trials.
This study tests a personalized home exercise program designed to reduce pain and fatigue in people with facioscapulohumeral muscular dystrophy (FSHD). It uses a smartphone app to guide exercises that may help you feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of FSHD type 1.
- You experience significant fatigue (score of 35 or higher on a fatigue scale).
- You can walk on your own and have no serious lung, heart, or nervous system problems.
- You do not have joint contractures (stiff, bent joints) or tendon tightness that would limit exercise.
- You own a smartphone and can use it for the exercise program.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well certain physical/movement tests work in people with facioscapulohumeral muscular dystrophy (FSHD). It may help clinicians measure changes more accurately and tailor care over time.
This study tests a personalized exercise program for people with rare neuromuscular diseases like FSHD, DM1, or CMT to see if it improves their physical function and quality of life.
This trial tests if a personalized home training program can help reduce severe fatigue in people with relapsing-remitting MS who were recently diagnosed. You'll use a phone app to do exercises designed for you, and researchers will check your energy levels over time.
This trial tests a home-based exercise program guided by a computer or tablet to help reduce fibromyalgia pain and improve daily function. It is designed for adults with fibromyalgia who can use a device and have internet access.
This study looks at how walking changes over time in people with facioscapulohumeral muscular dystrophy (FSHD). It aims to understand walking patterns to help improve future care.
This study tests a new medicine called SAT-3247 to see if it can safely improve muscle strength in people with facioscapulohumeral muscular dystrophy (FSHD), a condition that causes muscle weakness, especially in the face, shoulders, and legs. Participating may help you and future patients by finding a treatment that could slow or reduce muscle loss.
Hear when a new FSHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.